Arcutis Biotherapeutics, Inc. ARQT Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s unrealized gains on investments?
- Arcutis Biotherapeutics, Inc. (ARQT) reported unrealized gains on investments of $13K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s unrealized gains on investments changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s unrealized gains on investments decreased by 93.0% year-over-year, from $187K to $13K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s unrealized gains on investments?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s unrealized gains on investments has grown at a 80.5% compound annual growth rate (CAGR), from $7K to $134K.